Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
 
Currency:  $ £
Discounted Reports
MARKET RESEARCH SECTOR IN FOCUS
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare
Textiles
MARKET REPORT DETAIL

GILEAD SCIENCES - New HIV + HCV Products to Sustain the Growth Trajectory

Enquire | Email | Print

Published Date: Feb, 2013
Format: PDF
No of Pages: 8
 
 
Select pricing :
Change Currency: EURO | $ USD | £ GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents

Initial sales of newly added HIV products – Complera/ Eviplera (L, truvada + rilpivirine), Stribild (L in US, R in EU, truvada+ cobicistat+ elvitegravir) along with growth in other marketed products contributed to the impressive 4Q12/FY13 results of Gilead. Positive data of Sofosbuvir (PMI, PhIII) in combination with RBV in GT2/3 pts (12-wk treatment is non inferior to 48-wk treatment of IFN/RBV FISSION) and in combination with IFN/RBV in GT 1, 4, 5 and 6 reaffirms its best in class efficacy and safety and application in other HCV genotypes. Strategic decision to focus on hematologic cancers (detail in Appendix) is reflected in the recent licensing deal with MacroGenics (US based pvt, technology – Dual-Affinity Re-Targeting, or DART) and acquisition of YM Biosciences (CYT387, JAK1/2 inhibitor, PhII, MF) expanded GILD’s oncology portfolio.

Through life cycle management of products for HIV, late stage HCV drugs and focus on oncology/ hematology pipeline through acquisition/in –licensing, GILD presents a long term investment opportunity and is one of our top picks for FY13.


Related Reports:  

 

Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.

 

Top Go to top of the page

product id: 372904, price: INR 8486, MP Advisors

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
E-mail: info@bharatbook.com
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
 
GPlus
About Trust Online